Simon J Hawkins (Simon Hawkins)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Induced Pluripotent Stem Cells

Top Venues

Pharmaceutical research

Nature nanotechnology

GlaxoSmithKline Plc

University of Bristol (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Plc

United Kingdom

Clinical Research Director :: R&D

Education History

University of Bristol

United Kingdom

PHD :: Medicine

Publications

Debra J Tompson, Mark Whitaker, Rennan Pan, Geoffrey S Johnson, Teresa Fuller, Vanessa Zann, Litza McKenzie, Kathy Abbott Banner, Simon J Hawkins, Marcy Powell
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology. Pharmaceutical research 39 (1) (2022)
Debra J Tompson, Mark Whitaker, Rennan Pan, Geoffrey S Johnson, Teresa Fuller, Litza McKenzie, Vanessa Zann, Marcy Powell, Kathy Abbott Banner, Simon J Hawkins
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772. Pharmaceutical research 38 (7) (2021)
Simon J Hawkins, Lucy A Crompton, Aman Sood, Margaret Saunders, Noreen T Boyle, Amy Buckley, Aedín M Minogue, Sarah F McComish, Natalia Jiménez-Moreno, Oscar Cordero Llana, Petros Stathakos, Catherine E Gilmore, Stephen Kelly, Jon D Lane, C Patrick Case, Maeve A Caldwell
Nanoparticle-induced neuronal toxicity across placental barriers is mediated by autophagy and dependent on astrocytes. Nature nanotechnology 13 (5) (2018)